Found 15 results
Filters: Author is Brys, Miroslaw  [Clear All Filters]
2009
Glodzik L, de Santi S, Rich KE, Brys M, Pirraglia E, Mistur R, Switalski R, Mosconi L, Sadowski M, Zetterberg H et al..  2009.  Effects of memantine on cerebrospinal fluid biomarkers of neurofibrillary pathology.. J Alzheimers Dis. 18(3):509-13.
Glodzik-Sobanska L, Pirraglia E, Brys M, de Santi S, Mosconi L, Rich KE, Switalski R, Louis LSaint, Sadowski MJ, Martiniuk F et al..  2009.  The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease.. Neurobiol Aging. 30(5):672-81.
Zhan J, Brys M, Glodzik L, Tsui W, Javier E, Wegiel J, Kuchna I, Pirraglia E, Li Y, Mosconi L et al..  2009.  An entorhinal cortex sulcal pattern is associated with Alzheimer's disease.. Hum Brain Mapp. 30(3):874-82.
Brys M, Glodzik L, Mosconi L, Switalski R, de Santi S, Pirraglia E, Rich K, Kim BC, Mehta P, Zinkowski R et al..  2009.  Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.. J Alzheimers Dis. 16(2):351-62.
Brys M, Pirraglia E, Rich K, Rolstad S, Mosconi L, Switalski R, Glodzik-Sobanska L, de Santi S, Zinkowski R, Mehta P et al..  2009.  Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment.. Neurobiol Aging. 30(5):682-90.
Kamer AR, Craig RG, Pirraglia E, Dasanayake AP, Norman RG, Boylan RJ, Nehorayoff A, Glodzik L, Brys M, de Leon MJ.  2009.  TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects.. J Neuroimmunol. 216(1-2):92-7.